Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis01:21

Hematopoiesis

5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CNS relapse during menin inhibitor therapy.

Blood·2026
Same author

Mediator subunit MED4 enforces metastatic dormancy in breast cancer.

Nature cell biology·2026
Same author

Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors.

Blood cancer journal·2026
Same author

Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study.

Hematological oncology·2026
Same author

Reinventing biotech systems for patient impact.

Nature medicine·2026
Same author

Stag2 dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome.

Blood·2026

Related Experiment Video

Updated: Sep 5, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.3K

PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation.

Maria M Aivalioti1,2, Boris A Bartholdy1, Kith Pradhan3

  • 1Department of Cell Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.

Blood Cancer Discovery
|July 12, 2022
PubMed
Summary

Loss of TET2 function and PU.1 gene regulation changes promote aging hematopoietic stem cell transformation. This uncovers a methylation-sensitive network in acute myeloid leukemia (AML) development.

More Related Videos

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

8.6K
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.7K

Related Experiment Videos

Last Updated: Sep 5, 2025

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.3K
Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

8.6K
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.7K

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acquired mutations in TET2 are common in aging hematopoietic stem cells.
  • Hypermethylation around transcription factor binding sites, like PU.1, is observed but its functional role is unclear.

Purpose of the Study:

  • To investigate the functional relevance of TET2 loss and PU.1 regulation in hematopoietic stem cell transformation.
  • To identify molecular vulnerabilities in acute myeloid leukemia (AML).

Main Methods:

  • Utilized Tet2-deficient mouse models with heterozygous deletion of the PU.1 upstream regulatory region (UREΔ/WT).
  • Analyzed hematopoietic stem and progenitor cell transformation, gene expression, and DNA methylation patterns.
  • Compared findings with human AML patient data.

Main Results:

  • Tet2-deficient PU.1 UREΔ/WT mice developed aggressive, transplantable AML during aging.
  • Leukemic cells exhibited hypermethylation at PU.1 sites, impaired myeloid enhancer activation, and shared gene expression signatures with human AML.
  • Moderately impaired PU.1 mRNA expression was identified as a predisposing factor.

Conclusions:

  • Tet2 and PU.1 cooperate to suppress leukemogenesis.
  • A methylation-sensitive, PU.1-dependent gene network represents a unifying molecular vulnerability in AML.
  • This network may aid in identifying patients at risk for malignant transformation.